Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Relay Therapeutics Inc’s stock clocked out at $6.35, down -1.85% from its previous closing price of $6.47. In other words, the price has decreased by -$1.85 from its previous closing price. On the day, 0.88 million shares were traded. RLAY stock price reached its highest trading level at $6.62 during the session, while it also had its lowest trading level at $6.21.
Ratios:
To gain a deeper understanding of RLAY’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.64 and its Current Ratio is at 15.64. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
On April 20, 2023, Jefferies Upgraded its rating to Hold which previously was Underperform but kept the price unchanged to $12.50.
Raymond James Upgraded its Outperform to Strong Buy on April 19, 2023, while the target price for the stock was maintained at $29.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 29 ’24 when Catinazzo Thomas sold 10,780 shares for $8.56 per share. The transaction valued at 92,316 led to the insider holds 319,650 shares of the business.
Rahmer Peter sold 15,128 shares of RLAY for $125,260 on Jul 30 ’24. The insider now owns 405,637 shares after completing the transaction at $8.28 per share. On Jul 29 ’24, another insider, Rahmer Peter, who serves as the insider of the company, sold 13,523 shares for $8.54 each. As a result, the insider received 115,543 and left with 420,765 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 866267008 and an Enterprise Value of 228951088. For the stock, the TTM Price-to-Sale (P/S) ratio is 24.15 while its Price-to-Book (P/B) ratio in mrq is 1.24. Its current Enterprise Value per Revenue stands at 6.503 whereas that against EBITDA is -0.622.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $12.14, while it has fallen to a 52-week low of $5.70. The 50-Day Moving Average of the stock is -13.70%, while the 200-Day Moving Average is calculated to be -23.10%.
Shares Statistics:
It appears that RLAY traded 1.19M shares on average per day over the past three months and 696200 shares per day over the past ten days. A total of 127.46M shares are outstanding, with a floating share count of 91.72M. Insiders hold about 31.50% of the company’s shares, while institutions hold 67.65% stake in the company. Shares short for RLAY as of 1723680000 were 9053519 with a Short Ratio of 7.64, compared to 1721001600 on 8429792. Therefore, it implies a Short% of Shares Outstanding of 9053519 and a Short% of Float of 8.66.
Earnings Estimates
The company has 9.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.78, with high estimates of -$0.68 and low estimates of -$0.86.
Analysts are recommending an EPS of between -$2.7 and -$3.05 for the fiscal current year, implying an average EPS of -$2.89. EPS for the following year is -$3.12, with 10.0 analysts recommending between -$2.44 and -$3.44.
Revenue Estimates
A total of 9 analysts have provided revenue estimates for RLAY’s current fiscal year. The highest revenue estimate was $11.01M, while the lowest revenue estimate was $10M, resulting in an average revenue estimate of $10.15M. In the same quarter a year ago, actual revenue was $25.55M
